Neuroendocrine tumors of the colon: an analysis of the literature and own experience


Cite item

Full Text

Abstract

Neuroendocrine tumors (NET) of the colon and rectum are rare diseases. In the treatment of patients with these rare diseases one should follow special standards which are differed from the standards of adenocarcinoma treatment. This article has analyzed the modern national literature, as well as our own experience in the treatment of 9 patients with NET of the colon in the period of 2007 to 2015. Average age - 60±14.6 years. Only NET of the rectum was identified at the first stage of the cancer. Endoscopic surgery was performed in 3 patients: two patients underwent endoscopic removal of the tumor and one - transanal endoscopic microsurgery associated with full-thickness resection of the rectum. Right-sided hemicolectomy was performed in 3 patients and anterior resection of the rectum (ARR) - in 1 patient. All operations were performed using standard oncology protocol associated with D2 lymph node dissection. We estimated the long-term outcomes of patients’ treatment. We analyzed the proposed by European colleagues algorithm of the treatment tactics in patients with neuroendocrine tumors of the colon, which in our point of view could be useful in medical practice of Russian doctors.

About the authors

A V Kochatkov

Center Economopoulos of the Oncology Department of Surgical of the Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation

Email: 7510803@gmail.com
д-р мед. наук, рук. Центра онкоколопроктологии, отд-ния онкологии хирургического профиля ФГАУ ЛРЦ 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3

S Yu Bogomazova

Center Economopoulos of the Oncology Department of Surgical of the Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation

д-р мед. наук, зав. патологоанатомического отд-ния ФГАУ ЛРЦ 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3

A Z Negardinov

Center Economopoulos of the Oncology Department of Surgical of the Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation

врач-хирург отд-ния онкологии хирургического профиля ФГАУ ЛРЦ 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3

Yu V Alimova

I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

студентка 5-го курса ФГБОУ ВО Первый МГМУ им. И.М.Сеченова 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2

V K Lyadov

Center Economopoulos of the Oncology Department of Surgical of the Treatment and Rehabilitation Center of the Ministry of Health of the Russian Federation

канд. мед. наук, зав. отд-нием онкологии хирургического профиля ФГАУ ЛРЦ 125367, Russian Federation, Moscow, Ivan'kovskoe sh., d. 3

References

  1. De Lellis R.A, Lloyd R.V, Heitz P.U et al. World Health Organization classification of tumours, pathology and genetics of tumours of endocrine organs. Lyon: IARC, 2004.
  2. Caplin M, Sundin A, Nillson O et al. Barcelona Consensus Conference p. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: colorectal neuroendocrine neoplasms. Neuroendocrinology 2012; 95 (2): 88-97.
  3. WHO classification of tumours of the digestive system. World Health Organization classification of tumours. Bosman FT. World Health Organization., International Agency for Research on Cancer. World Health Organization classification of tumours. Lyon: International Agency for Research on Cancer, 2010; 3.
  4. Anthony L.B, Strosberg J.R, Klimstra D.S et al. The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well - differentiated nets of the distal colon and rectum. Pancreas 2010; 39 (6): 767-74.
  5. Пинский С.Б., Белобородов В.А., Батороев Ю.К., Дворниченко В.В. Нейроэндокринные опухоли желудочно - кишечного тракта (сообщение 5). Нейроэндокринные опухоли ободочной и прямой кишки. Сиб. мед. жур. 2015; 134 (3): 38-43.
  6. Шелехов А.В. и др. Результаты паллиативного и радикального лечения новообразований прямой кишки методом трансанальной эндомикрохирургии. Паллиативная медицина и реабилитация. 2007; 1: 11-2.
  7. Карасев И.А., Перфильев И.Б., Мазуров С.Т., Поддубный Б.К. Комплексное применение эндоскопических методов в диагностике ранних форм рака толстой кишки. Онкологическая колопроктология. 2013; 2 (2): 40-5.
  8. Карасев И.А., Перфильев И.Б., Мазуров С.Т. и др. Комплексное применение современных эндоскопических методов в уточненной диагностике эпителиальных опухолей толстой кишки. Вестн. Национального медико - хирургического Центра им. Н.И. Пирогова. 2013; 8 (4): 78-82.
  9. Барсуков Ю.А., Алиев В.А., Перевощиков А.Г. и др. Крупноклеточный нейроэндокринный рак прямой кишки. Вестник РОНЦ им. Н.Н. Блохина РАМН. 2009; 20 (2): 52-7.
  10. Сидоров Д.В., Бутенко А.В., Тепляков В.В. и др. Клиническое наблюдение нейроэндокринной опухоли прямой кишки. Онкология. Журн. им. П.А.Герцена. 2013; 2: 58-9.
  11. Шелыгин Ю.А., Чернышов С.В., Пересада И.В. и др. Первый опыт трансанальных эндоскопических операций. Колопроктология. 2012; 2: 34-9.
  12. Хижа В.В., Чернов К.Е., Артюшин Б.С и др. Нерешенные задачи обследования и лечения пациентов при карциноидах желудочно - кишечного тракта. Фундаментальные исследования. 2010; 2 (2): 132-7.
  13. Мовчан К.Н., Хижа В.В., Чернов К.Е. и др. Проблемы оказания медицинской помощи больным карциноидами органов системы пищеварения. Вестн. Новгородского гос. универ. им. Я.Мудрого. 2010; 59 (59): 106-9.
  14. Мовчан К.Н., Хижа В.В., Кисленко А.М. и др. Возможности ранней верификации карциноидов толстой кишки. Анналы хирургии. 2011; 1: 48-52.
  15. Ramage J, De Herder W.W, Delle Fave G.F et al. Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms (NEN). Neuroendocrinology 2016; 10: 1159/000443166.
  16. Weinstock B, Ward S, Harpaz N et al. Clinical and prognostic features of rectal neuroendocrine tumors. Neuroendocrinology 2013; 98 (3): 180-7.
  17. Arezzo A, Passera R, Saito Y. Systematic review and meta - analysis of endoscopic submucosal dissection versus transanal endoscopic microsurgery for large noninvasive rectal lesions. Surg Endosc 2014; 28 (2): 427-38.
  18. Pattison D.A, Hofman M.S. Role of Fluorodeoxyglucose PET. Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies. PET Clin 2015; 10 (4): 461-76.
  19. Van Essen M, Krenning E.P, Kam B.L. Peptide - receptor radionuclide therapy for endocrine tumors. Nat Rev Endocrinol 2009; 5 (7): 382-93.

Copyright (c) 2016 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies